79 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
and our assessment of potential acquisition or in-licensing opportunities require substantial technical, financial and human resources, regardless … be enforced through civil whistleblower, or qui tam actions, as well as civil monetary penalty laws can impose criminal and civil penalties, assessment
8-K
EX-1.1
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Entry into a Material Definitive Agreement
4:15pm
or similar assessment, fine or penalty levied against it except as may be being contested in good faith and by appropriate proceedings. To the extent required
424B5
XENE
Xenon Pharmaceuticals Inc
29 Nov 23
Prospectus supplement for primary offering
5:05pm
as NBI-921352. Both our internal discovery efforts and our assessment of potential acquisition or in-licensing opportunities require substantial … impose criminal and civil penalties, assessment, and exclusion from participation for various forms of fraud and abuse involving the federal health
424B5
mjpmi379yfx
23 Jun 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-1.1
t3l5oh0
23 Jun 22
Other Events
4:04pm
424B5
oo5yo8o1c82z0q
22 Jun 22
Prospectus supplement for primary offering
4:05pm
424B5
rzg6aep y1
1 Mar 22
Prospectus supplement for primary offering
5:12pm
8-K
EX-10.1
tezgdil0n0yngfzoas
1 Dec 21
Entry into a Material Definitive Agreement
4:02pm
424B5
tt3dp4r372c5mph
6 Oct 21
Prospectus supplement for primary offering
5:05pm